Published in J Bone Miner Res on June 01, 2000
Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ (2009) 7.64
Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int (2008) 3.48
Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract (2011) 2.29
Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int (2005) 2.11
Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis. J Am Geriatr Soc (2010) 2.10
Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci (2007) 1.84
Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients (2013) 1.81
Benefit-risk assessment of vitamin D supplementation. Osteoporos Int (2009) 1.70
Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int (2015) 1.60
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ (2010) 1.45
Role of vitamin D in adults requiring nutrition support. JPEN J Parenter Enteral Nutr (2009) 1.40
Vitamin D and its role in skeletal muscle. Curr Opin Clin Nutr Metab Care (2009) 1.27
The 6-minute walk is associated with frailty and predicts mortality in older adults with heart failure. Congest Heart Fail (2010) 1.26
Prevention of falls in the elderly--a review. Osteoporos Int (2013) 1.25
Higher 1,25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women. Osteoporos Int (2006) 1.22
Reporting of complex interventions in clinical trials: development of a taxonomy to classify and describe fall-prevention interventions. Trials (2011) 1.17
Falls: epidemiology, pathophysiology, and relationship to fracture. Curr Osteoporos Rep (2008) 1.16
Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol. Rheumatol Int (2004) 1.15
A randomized study on the effect of vitamin D₃ supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J Clin Endocrinol Metab (2013) 1.15
Prevention of falls and fall-related injuries in community-dwelling seniors: an evidence-based analysis. Ont Health Technol Assess Ser (2008) 1.10
How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int (2006) 1.08
Vitamin D: a critical and essential micronutrient for human health. Front Physiol (2014) 1.05
Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int (2012) 1.05
Recent developments in vitamin D deficiency and muscle weakness among elderly people. BMJ (2005) 1.05
Is fall prevention by vitamin D mediated by a change in postural or dynamic balance? Osteoporos Int (2006) 1.04
Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease. J Gen Intern Med (2002) 1.04
Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle. J Mol Histol (2010) 1.03
The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int (2004) 1.00
Relationships between serum vitamin D levels, neuromuscular and neuropsychological function and falls in older men and women. Osteoporos Int (2011) 0.98
Is vitamin D a determinant of muscle mass and strength? J Bone Miner Res (2011) 0.96
Vitamin D insufficiency in Japanese populations: from the viewpoint of the prevention of osteoporosis. J Bone Miner Metab (2006) 0.96
Impact of supplementation with bicarbonate on lower-extremity muscle performance in older men and women. Osteoporos Int (2009) 0.95
Calcium nutrition and extracellular calcium sensing: relevance for the pathogenesis of osteoporosis, cancer and cardiovascular diseases. Nutrients (2013) 0.94
An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment. J Clin Endocrinol Metab (2006) 0.93
Vitamin D status in women with pelvic floor disorder symptoms. Int Urogynecol J (2012) 0.91
How much vitamin D do we need for skeletal health? Clin Orthop Relat Res (2011) 0.91
Carla Task Force on Sarcopenia: propositions for clinical trials. J Nutr Health Aging (2009) 0.90
Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease. Osteoporos Int (2004) 0.90
Effects of vitamin D in the elderly population: current status and perspectives. Arch Public Health (2014) 0.90
Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS). Osteoporos Int (2009) 0.90
Falls are associated with decreased renal function and insufficient calcitriol production by the kidney. J Steroid Biochem Mol Biol (2006) 0.89
A case study of discordant overlapping meta-analyses: vitamin d supplements and fracture. PLoS One (2014) 0.89
What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis? Osteoporos Int (2010) 0.89
Fracture prevention with vitamin D supplementation: considering the inconsistent results. BMC Musculoskelet Disord (2007) 0.88
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations. Endocr Pract (2011) 0.88
Additive benefit of higher testosterone levels and vitamin D plus calcium supplementation in regard to fall risk reduction among older men and women. Osteoporos Int (2008) 0.87
How I treat vitamin d deficiency. J Oncol Pract (2010) 0.87
Effects of vitamin d on muscle function and performance: a review of evidence from randomized controlled trials. Ther Adv Chronic Dis (2011) 0.87
Dementia and hip fractures: development of a pathogenic framework for understanding and studying risk. Geriatr Orthop Surg Rehabil (2010) 0.87
Serum 25-hydroxyvitamin D levels and activities of daily living in noninstitutionalized elderly Japanese requiring care. J Bone Miner Metab (2005) 0.86
Serum 25-hydroxyvitamin D concentration and physical function in adult men. Clin Endocrinol (Oxf) (2011) 0.86
Vitamin D(3) at 50x AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females. PLoS One (2013) 0.85
How pleiotropic genetics of the musculoskeletal system can inform genomics and phenomics of aging. Age (Dordr) (2010) 0.84
Supplemental vitamin D and physical performance in COPD: a pilot randomized trial. Int J Chron Obstruct Pulmon Dis (2013) 0.84
Femoral bone mineral density in patients with heart failure. Osteoporos Int (2006) 0.84
The implications of a growing evidence base for drug use in elderly patients. Part 4. Vitamin D and bisphosphonates for fractures and osteoporosis. Br J Clin Pharmacol (2006) 0.81
Vitamin D and bone health: potential mechanisms. Nutrients (2010) 0.81
Comparison of cost-effectiveness of vitamin D screening with that of universal supplementation in preventing falls in community-dwelling older adults. J Am Geriatr Soc (2013) 0.81
The emerging biomolecular role of vitamin D in skeletal muscle. Exerc Sport Sci Rev (2014) 0.80
Independent from muscle power and balance performance, a creatinine clearance below 65 ml/min is a significant and independent risk factor for falls and fall-related fractures in elderly men and women diagnosed with osteoporosis. Osteoporos Int (2009) 0.80
Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass. Rheumatol Int (2010) 0.80
The relationship between balance control and vitamin D in Parkinson's disease-a pilot study. Mov Disord (2013) 0.80
Study protocol for prevention of falls: a randomized controlled trial of effects of vitamin D and exercise on falls prevention. BMC Geriatr (2012) 0.79
The Association between Seasonal Variation in Vitamin D, Postural Sway, and Falls Risk: An Observational Cohort Study. J Aging Res (2013) 0.79
Osteoporosis screening and risk management. Clin Interv Aging (2007) 0.79
Abdominal obesity is an independent predictor of serum 25-hydroxyvitamin D deficiency in adults with cerebral palsy. Nutr Metab (Lond) (2014) 0.78
Calcium plus vitamin D supplementation has limited effects on femoral geometric strength in older postmenopausal women: the Women's Health Initiative. Calcif Tissue Int (2011) 0.78
Postural stabilizing effect of alfacalcidol and active absorbable algal calcium (AAA Ca) compared with calcium carbonate assessed by computerized posturography. J Bone Miner Metab (2007) 0.78
Vitamin D supplement intake in elderly fallers. J Am Geriatr Soc (2009) 0.77
Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes. Clin Cases Miner Bone Metab (2010) 0.77
Prevalence and Factors Associated with Vitamin D Deficiency and Hyperparathyroidism in HIV-Infected Patients Treated in Barcelona. ISRN AIDS (2012) 0.77
Rheumatology and musculoskeletal medicine. Br J Gen Pract (2004) 0.77
[Primary and secondary osteoporosis. The important role of internal medicine in its differential diagnosis]. Internist (Berl) (2005) 0.77
Evidence for the treatment of osteoporosis with vitamin D in residential care and in the community dwelling elderly. Biomed Res Int (2013) 0.77
Vitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson's disease. Ther Clin Risk Manag (2013) 0.76
[Relative value of plain vitamin D and of biologically active vitamin D in the prevention and treatment of osteoporosis]. Z Rheumatol (2006) 0.76
Vitamin D supplementation to prevent depression and poor physical function in older adults: Study protocol of the D-Vitaal study, a randomized placebo-controlled clinical trial. BMC Geriatr (2015) 0.76
25-hydroxyvitamin D, parathyroid hormone, and functional recovery after hip fracture in elderly patients. J Bone Miner Metab (2006) 0.76
Determinants of living situation in a population of community-dwelling and assisted living-dwelling elders. J Am Med Dir Assoc (2010) 0.75
Functional Improvement in Geriatric Hip Fractures: Does Vitamin D Deficiency Affect the Functional Outcome of Patients With Surgically Treated Intertrochanteric Hip Fractures. Geriatr Orthop Surg Rehabil (2015) 0.75
Declaration on Vitamin D in Osteoporosis Management: From the European Summit on the Role of Vitamin D in the Management of Osteoporosis: a MetaForum. Clin Cases Miner Bone Metab (2007) 0.75
Clinical challenges in the management of osteoporosis. Clin Interv Aging (2008) 0.75
Fat and Bone: An Odd Couple. Front Endocrinol (Lausanne) (2016) 0.75
Clinical pharmacology of old age syndromes. Br J Clin Pharmacol (2003) 0.75
Vitamin D and Age-Related Health Outcomes: Movement, Mood, and Memory. Curr Nutr Rep (2015) 0.75
Serum 25-hydroxyvitamin D levels are associated with functional capacity but not with postural balance in osteoporotic postmenopausal women. Clinics (Sao Paulo) (2017) 0.75
Physical performance and life quality in postmenopausal women supplemented with vitamin D: a two-year prospective study. Acta Pharmacol Sin (2015) 0.75
Social Disadvantage Is Associated With Lower Vitamin D Levels in Older People and There Is No Surrogate for Its Measurement. Gerontol Geriatr Med (2017) 0.75
Vitamin D: Musculoskeletal health. Rev Endocr Metab Disord (2016) 0.75
Vitamin D and Pelvic Floor Disorders. J Midlife Health (2017) 0.75
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med (1995) 10.99
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int (2000) 4.85
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta (1991) 4.16
Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab (2001) 3.51
Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int (2008) 3.48
Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int (1998) 2.45
Vitamin D and muscle function. Osteoporos Int (2002) 2.17
The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial. Ann Intern Med (1998) 2.14
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer. Ann Oncol (2007) 2.03
The development of a risk-adjusted capitation payment system: the Maryland Medicaid model. J Ambul Care Manage (1998) 1.86
Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta (1991) 1.75
Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry (2011) 1.69
Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel. Am J Physiol (1998) 1.63
Exclusion of SNRPN as a major determinant of Prader-Willi syndrome by a translocation breakpoint. Nat Genet (1996) 1.53
Response to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupus. Lupus (2012) 1.52
Distinct p53/56lyn and p59fyn domains associate with nonphosphorylated and phosphorylated Ig-alpha. Proc Natl Acad Sci U S A (1994) 1.49
High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics (1986) 1.49
Cloning the mouse homolog of the human cystic fibrosis transmembrane conductance regulator gene. Genomics (1991) 1.48
Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B. Clin Genet (2011) 1.42
Wine for type 2 diabetic patients? Diabet Med (1993) 1.41
Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim Biophys Acta (1989) 1.40
Influence of vessel size on early and late outcomes after primary angioplasty for acute myocardial infarction. J Invasive Cardiol (2000) 1.39
Development of the National Institutes of Health genetically heterogeneous rat stock. Alcohol Clin Exp Res (1984) 1.39
Cognitive-behavioral treatment of school phobia. J Am Acad Child Adolesc Psychiatry (1998) 1.36
Role of the thymus in directing the development of a subset of B lymphocytes. J Exp Med (1982) 1.32
A study of complaints and their relation to vertebral destruction in patients with osteoporosis. Bone Miner (1990) 1.30
Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation (1988) 1.24
Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes (2001) 1.22
Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate. Br J Cancer (1999) 1.19
Possible salt bridges between transmembrane alpha-helices of the lactose carrier of Escherichia coli. J Biol Chem (1992) 1.15
Pediatric HIV infection in Elista, Russia: interventional strategies. Am J Public Health (1995) 1.15
Identification and fine mapping of quantitative trait loci for growth traits on bovine chromosomes 2, 6, 14, 19, 21, and 23 within one commercial line of Bos taurus. J Anim Sci (2004) 1.14
Clinical grading of spinal osteoporosis: quality of life components and spinal deformity in women with chronic low back pain and women with vertebral osteoporosis. J Bone Miner Res (1997) 1.13
Chemotactic response of osteoblastlike cells to transforming growth factor beta. J Bone Miner Res (1990) 1.13
Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta. Endocrinology (1990) 1.12
Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol Chem (1995) 1.10
Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Ann Rheum Dis (1997) 1.08
Idiopathic trigeminal sensory neuropathy with gadolinium enhancement in the cisternal segment. Neurology (2000) 1.07
Radiographers and trainee radiologists reporting accident radiographs: a comparative plain film-reading performance study. Clin Radiol (2012) 1.07
An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Carcinogenesis (1996) 1.05
Depressed cholinesterase activities among farm workers in New Jersey. Sci Total Environ (1976) 1.05
Anxious children in adulthood: a prospective study of adjustment. J Am Acad Child Adolesc Psychiatry (1997) 1.04
Polymorphisms in the bovine leptin promoter associated with serum leptin concentration, growth, feed intake, feeding behavior, and measures of carcass merit. J Anim Sci (2005) 1.03
Time since vertebral fracture: an important variable concerning quality of life in patients with postmenopausal osteoporosis. Osteoporos Int (1999) 1.02
Clinical evaluation criteria for the assessment of impaired pain sensitivity by thulium-laser evoked potentials. Clin Neurophysiol (2000) 1.02
DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient. Transpl Infect Dis (2012) 1.02
Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine. Cancer Res (1992) 1.02
Adaptation of the Diabetes Health Profile (DHP-1) for use with patients with Type 2 diabetes mellitus: psychometric evaluation and cross-cultural comparison. Diabet Med (2000) 1.01
Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol (2000) 1.00
Identification and fine mapping of quantitative trait loci for backfat on bovine chromosomes 2, 5, 6, 19, 21, and 23 in a commercial line of Bos taurus. J Anim Sci (2004) 1.00
Iron supplementation in athletes. Current recommendations. Sports Med (1998) 0.99
Assessment of positional candidate genes myf5 and igf1 for growth on bovine chromosome 5 in commercial lines of Bos taurus. J Anim Sci (2004) 0.99
Fine mapping of quantitative trait loci and assessment of positional candidate genes for backfat on bovine chromosome 14 in a commercial line of Bos taurus. J Anim Sci (2003) 0.98
Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Exp Clin Endocrinol (1994) 0.98
Muscarinic K+ channel in the heart. Modal regulation by G protein beta gamma subunits. J Gen Physiol (1998) 0.98
Structure of apoptosis-linked protein ALG-2: insights into Ca2+-induced changes in penta-EF-hand proteins. Structure (2001) 0.98
[Osteoporosis]. Internist (Berl) (2002) 0.97
Ribozyme-mediated suppression of the G protein gamma7 subunit suggests a role in hormone regulation of adenylylcyclase activity. J Biol Chem (1997) 0.96
Mapping of the human PAWR (par-4) gene to chromosome 12q21. Genomics (1998) 0.96
Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut (1998) 0.95
In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin. Mol Cell Neurosci (2000) 0.94
X-linked congenital ptosis and associated intellectual disability, short stature, microcephaly, cleft palate, digital and genital abnormalities define novel Xq25q26 duplication syndrome. Hum Genet (2013) 0.94
Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify "septic" intensive care unit patients. Shock (2000) 0.94
Antioxidant capacity, phenolic content, and polysaccharide content of Lentinus edodes grown in whey permeate-based submerged culture. J Food Sci (2008) 0.92
Ultraviolet A irradiation stimulates collagenase production in cultured human fibroblasts. J Invest Dermatol (1992) 0.92
Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs--an analysis using national health databases. Osteoporos Int (2013) 0.92
MECP2 mutations in Danish patients with Rett syndrome: high frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern. Eur J Hum Genet (2001) 0.91
Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens. J Clin Endocrinol Metab (1996) 0.90
Discrepancies in the determination of sperm concentration using Bürker-Türk, Thoma and Makler counting chambers. Theriogenology (2005) 0.90
Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy. Clin Immunol Immunopathol (1994) 0.89
Preparation of single-stranded deoxyribonucleic acid probes using an immobilized template. Anal Biochem (1987) 0.89
Analysis of orbital T cells in thyroid-associated ophthalmopathy. Clin Exp Immunol (1998) 0.88
A family-based investigation of cold pain tolerance. Pain (2008) 0.88
Systemic mastocytosis and skeletal lesions. Lancet (1997) 0.87
Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly. Horm Metab Res (1991) 0.87
Sequence variants in the human cocaine and amphetamine-regulated transcript (CART) gene in subjects with early onset obesity. Obes Res (1999) 0.87
Prostaglandin E production and hypercalcaemia in rats bearing the Walker carcinosarcoma. Br J Cancer (1980) 0.87
Alpha-1 adrenergic signaling in a cardiac murine atrial myocyte (HL-1) cell line. Mol Cell Biochem (2000) 0.87
Constitutively active mutants of the alpha(1a)- and the alpha(1b)-adrenergic receptor subtypes reveal coupling to different signaling pathways and physiological responses in rat cardiac myocytes. J Biol Chem (2000) 0.87
Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells. Biochem Pharmacol (1997) 0.87
Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol (1999) 0.87
Inflammation-mediated osteopenia in the rat: a new animal model for pathological loss of bone mass. Endocrinology (1984) 0.86
Influence of inflammation-mediated osteopenia on the regional acceleratory phenomenon and the systemic acceleratory phenomenon during healing of a bone defect in the rat. Calcif Tissue Int (1998) 0.86
Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol Int (2002) 0.86
Hospital charges for antibiotics. Rev Infect Dis (1985) 0.86
Impaired mitogen-activated protein kinase activation and altered cytokine secretion in endotoxin-tolerant human monocytes. J Trauma (2000) 0.86
Effect of alcohol on glucose, insulin, free fatty acid and triacylglycerol responses to a light meal in non-insulin-dependent diabetic subjects. Br J Nutr (1994) 0.86
Cervical sonography in pregnant women with a prior cone biopsy or loop electrosurgical excision procedure. Ultrasound Obstet Gynecol (2010) 0.86
Effects of cyclopentolate eyedrops on gastric secretory function in pre-term infants. Ophthalmology (1985) 0.85
Effects of fluoride on rat vertebral body biomechanical competence and bone mass. Bone (1995) 0.85